Cargando…

Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia

Cell-free mitochondrial DNA (cf-mtDNA) is a damage-associated molecular pattern that boosts the release of cytokines and induces the immune response of the body; therefore, it is closely related to mental diseases. This study aims to evaluate a potential link between cf-mtDNA and clinical progressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouyang, Houxian, Huang, Minfang, Xu, Yongming, Yao, Qin, Wu, Xiangping, Zhou, Dongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292716/ https://www.ncbi.nlm.nih.gov/pubmed/34305669 http://dx.doi.org/10.3389/fpsyt.2021.652314

Ejemplares similares

Analysis of polyunsaturated fatty acids in antipsychotic-free individuals with at-risk mental state and patients with first-episode schizophrenia
por: Le, Anh Thi Phuong, et al.
Publicado: (2023)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
por: Cheng, Zhang, et al.
Publicado: (2020)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Yin, Ping, et al.
Publicado: (2021)

The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies
por: Yang, Chengmin, et al.
Publicado: (2021)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
por: Li, Jinguang, et al.
Publicado: (2020)

Auditory Event-Related Potentials in Antipsychotic-Free Subjects With Ultra-High-Risk State and First-Episode Psychosis
por: Hsieh, Ming H., et al.
Publicado: (2019)

COMT, 5-HTR2A, and SLC6A4 mRNA Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association With Treatment Outcomes
por: Li, Zongchang, et al.
Publicado: (2018)

Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR
por: Stürup, Anne Emilie, et al.
Publicado: (2022)

Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients
por: Zhou, Xiang, et al.
Publicado: (2020)

Reduced Dorsal Visual Oscillatory Activity During Working Memory Maintenance in the First-Episode Schizophrenia Spectrum
por: Coffman, Brian A., et al.
Publicado: (2020)

Impaired Emotional Self-Referential Processing in First-Episode Schizophrenia
por: Zhao, Yanli, et al.
Publicado: (2021)

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia
por: Sun, Qiaoling, et al.
Publicado: (2022)

Associations Among Suicidal Ideation, White Matter Integrity and Cognitive Deficit in First-Episode Schizophrenia
por: Long, Yicheng, et al.
Publicado: (2018)

Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
por: Leppik, Liisa, et al.
Publicado: (2018)

Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia
por: Wu, Renrong, et al.
Publicado: (2019)

Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia
por: Tao, Qi, et al.
Publicado: (2020)

Altered Functional Connectivity of Striatum Based on the Integrated Connectivity Model in First-Episode Schizophrenia
por: Zhang, Bei, et al.
Publicado: (2019)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013)

Abnormal Brain Network Interaction Associated With Positive Symptoms in Drug-Naive Patients With First-Episode Schizophrenia
por: Yuan, Liu, et al.
Publicado: (2022)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

Physical Activity in Schizophrenia is Higher in the First Episode than in Subsequent Ones
por: Walther, Sebastian, et al.
Publicado: (2015)

Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients
por: Liu, Yong, et al.
Publicado: (2019)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Nakajima, Suguru, et al.
Publicado: (2021)

Increased brain gyrification and subsequent relapse in patients with first-episode schizophrenia
por: Sasabayashi, Daiki, et al.
Publicado: (2022)

Core of sensory gating deficits in first-episode schizophrenia: attention dysfunction
por: Ding, Yushen, et al.
Publicado: (2023)

Effects of Long-Term Multimodal Psychosocial Treatment on Antipsychotic-Induced Metabolic Changes in Patients With First Episode Psychosis
por: Rojnic Kuzman, Martina, et al.
Publicado: (2018)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
por: Giordano, Gloria, et al.
Publicado: (2020)

The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
por: Li, Xue, et al.
Publicado: (2021)

A Deformation-Based Shape Study of the Corpus Callosum in First Episode Schizophrenia
por: Huang, Weikai, et al.
Publicado: (2021)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
por: Koricanac, Aleksandra, et al.
Publicado: (2022)

Relationship between Brain-Derived Neurotrophic Factor and Schneiderian First Rank Symptoms in Antipsychotic-Naïve Schizophrenia
por: Kalmady, Sunil Vasu, et al.
Publicado: (2013)

Association between Unmet Needs and Clinical Status in Patients with First Episode of Schizophrenia in Chile
por: Jorquera, Natalia, et al.
Publicado: (2015)

Decreased Left Putamen and Thalamus Volume Correlates with Delusions in First-Episode Schizophrenia Patients
por: Huang, Xiaojun, et al.
Publicado: (2017)

Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients
por: Yan, Junwei, et al.
Publicado: (2022)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis
por: Liu, Chen-Chung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vjb05no742irdso9tdrdkkieqv